Experimental cancer drug trial ends early after just 5 patients
Disease control
Terminated
This study tested an experimental drug called IBI3004 in people with advanced solid tumors that could not be removed by surgery. The goal was to find a safe dose and check for side effects. Only 5 people took part before the study was stopped early, so results are very limited.
Phase: PHASE1, PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC